{
    "1686068965661949957": {
        "author_id": "5383942",
        "created_at": "2023-07-31T17:39:01.000Z",
        "edit_history_tweet_ids": [
            "1686068965661949957"
        ],
        "entities": {
            "annotations": [
                {
                    "end": 123,
                    "normalized_text": "cancer",
                    "probability": 0.5891,
                    "start": 118,
                    "type": "Other"
                }
            ],
            "hashtags": [
                {
                    "end": 19,
                    "start": 9,
                    "tag": "Investors"
                },
                {
                    "end": 30,
                    "start": 24,
                    "tag": "Media"
                },
                {
                    "end": 124,
                    "start": 117,
                    "tag": "cancer"
                }
            ],
            "mentions": [
                {
                    "end": 50,
                    "id": "208120290",
                    "start": 43,
                    "username": "US_FDA"
                }
            ]
        },
        "id": "1686068965661949957",
        "lang": "en",
        "public_metrics": {
            "bookmark_count": 0,
            "impression_count": 5530,
            "like_count": 17,
            "quote_count": 0,
            "reply_count": 3,
            "retweet_count": 4
        },
        "text": "News for #Investors and #Media: Today, the @US_FDA has granted approval for a new indication for our immuno-oncology #cancer therapy. Learn more:"
    }
}